Join
Live feed
·
INSIDERFilingvia Quantisnow
Deciphera Pharmaceuticals Inc. logo

SVP, Chief Development Officer Pitman Jama was granted 20,163 shares and returned 53,951 shares to the company, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
DCPH· Deciphera Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DCPH (Deciphera Pharmaceuticals Inc.) and more on Quantisnow.